[Inter- and intra-cephalic variations in pathogenicity in Toxoplasma gondii. Clinical and epidemiologic consequences]

Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

[Inter- and intra-cephalic variations in pathogenicity in Toxoplasma gondii. Clinical and epidemiologic consequences]

Bull Acad Natl Med. 1993 Nov;177(8):1411-9; discussion 1419-21. Unique Identifier : AIDSLINE MED/94251636
Ambroise-Thomas P; Okay T; Departement de Parasitologie-Mycologie Medicale et; Moleculaire, Faculte de Medecine, Universite Joseph Fourier,; Grenoble.

Abstract: Clinical and epidemiological studies, especially the ones conducted in HIV+ patients indicate that the pathogenicity of Toxoplasma gondii varies according to the strain considered. The differences observed among strains are represented by distinct genomic DNA patterns which could be experimentally evaluated by means of the RFLP (Restriction Fragment Length Polymorphism) and the RAPD (Random Amplified Polymorphic DNA). If on the one hand virulent strains present very similar genomic DNA patterns, on the other hand chronic strains are highly polymorphic. These differences may be, at least in part, due to the asexual (clonal) multiplication of virulent strains. The existence of an intraspecific pathogenicity variation and genetic heterogeneity was observed within a single strain either after attenuation (infection in Fischer or Wistar rats), or during reactivation (in immunodepressed animals). In a congenital model of toxoplasmosis, the differences are detected from one animal to another and sometimes, even from one organ to another in the same host. This finding do not seem to be related to the occurrence of mutations but rather to selective pressures, notably of immunological origin, exerted by the infected organism. A better understanding of these phenomena could result in significant therapeutic and prophylactic advances. Our first effort will be directed to the establishment of more precise diagnostic and predictive elements. The accomplishment of this step relies on the use of primers deriving from DNA sequences characteristic of virulence and which will be tested by PCR.

Keywords: Animal English Abstract Human Rats Rats, Inbred F344 Rats, Wistar Toxoplasma/*PATHOGENICITY Toxoplasmosis/*EPIDEMIOLOGY/THERAPY Toxoplasmosis, Animal/*CONGENITAL JOURNAL ARTICLE

940930
M9491013

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .